Hansoh Pharmaceutical Group Company Limited

Hansoh Pharmaceutical Group Company Limitedverified

3692.HK

Price:

$37.78

Market Cap:

$202.87B

Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company provides products for therapeutic areas, including central nervous system diseases, oncology, anti-infectives, and metabolic diseases. Its principal products include Mailingda, a drug for the treatment of chronic myelogenous leukemia; and Ameile, Hansoh Xinfu, Pulaile, Zefei, Xinwei, Xinmei, Xintai, Tanneng, Oulanning, Ameining, Zetan, Hengjie, Hengsen, Fulaimei, Fulaidi, and Ruibote drugs. The company serves pharmaceutical product distributors. It has a strategic collaboration with Sc...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2019-06-14

Stock Exchange

HKSE

Ticker

3692.HK

The ROE as of December 2025 (TTM) for Hansoh Pharmaceutical Group Company Limited (3692.HK) is 16.00%

According to Hansoh Pharmaceutical Group Company Limited’s latest financial reports and current stock price. The company's current ROE is 16.00%. This represents a change of 92.16% compared to the average of 8.32% of the last 4 quarters.

Hansoh Pharmaceutical Group Company Limited (3692.HK) Historical ROE (quarterly & annually)

How has 3692.HK ROE performed in the past?

The mean historical ROE of Hansoh Pharmaceutical Group Company Limited over the last ten years is 39.20%. The current 16.00% ROE has changed -59.19% with respect to the historical average. Over the past ten years (40 quarters), 3692.HK's ROE was at its highest in in the December 2018 quarter at 65.63%. The ROE was at its lowest in in the January 2016 quarter at 0%.

Quarterly (TTM)
Annual

Average

39.20%

Median

15.24%

Minimum

11.41%

Maximum

145.09%

Hansoh Pharmaceutical Group Company Limited (3692.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Hansoh Pharmaceutical Group Company Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 254.79%

Maximum Annual ROE = 145.09%

Minimum Annual Increase = -86.49%

Minimum Annual ROE = 11.41%

Quarterly (TTM)
Annual
YearROEChange
202415.24%19.97%
202312.71%11.37%
202211.41%-15.77%
202113.54%-5.75%
202014.37%-26.68%
201919.60%-86.49%
2018145.09%254.79%
201740.90%-48.83%

Hansoh Pharmaceutical Group Company Limited (3692.HK) Average ROE

How has 3692.HK ROE performed in the past?

The current ROE of Hansoh Pharmaceutical Group Company Limited (3692.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.12%

5-year avg

13.45%

10-year avg

39.20%

Hansoh Pharmaceutical Group Company Limited (3692.HK) ROE vs. Peers

How is 3692.HK’s ROE compared to its peers?

Hansoh Pharmaceutical Group Company Limited’s ROE is less than JD Health International Inc. (8.34%), less than WuXi Biologics (Cayman) Inc. (9.67%), less than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (6.89%), less than Innovent Biologics, Inc. (8.22%), less than WuXi AppTec Co., Ltd. (23.34%), less than Sino Biopharmaceutical Limited (11.85%), less than China Medical System Holdings Limited (9.90%), less than Grand Pharmaceutical Group Limited (12.37%), less than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (8.00%), less than China Resources Pharmaceutical Group Limited (5.79%),

Build a custom stock screener for Hansoh Pharmaceutical Group Company Limited (3692.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hansoh Pharmaceutical Group Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hansoh Pharmaceutical Group Company Limited (3692.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hansoh Pharmaceutical Group Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Hansoh Pharmaceutical Group Company Limited's ROE?

How is the ROE calculated for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

What is the highest ROE for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

What is the 3-year average ROE for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

What is the 5-year average ROE for Hansoh Pharmaceutical Group Company Limited (3692.HK)?

How does the current ROE for Hansoh Pharmaceutical Group Company Limited (3692.HK) compare to its historical average?